A Single- and Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3954068 in Patients with Early Symptomatic Alzheimer's Disease
Clinical Trial Grant
Awarded By
Lilly USA, LLC
Start Date
January 9, 2025
End Date
August 31, 2029
Awarded By
Lilly USA, LLC
Start Date
January 9, 2025
End Date
August 31, 2029